Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    tarsa
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Oral Calcitonin Tablets;   Drug: Intranasal Calcitonin;   Drug: Placebo tablets and placebo intranasal spray
2 Completed
Has Results
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Condition: Osteopenia
Interventions: Drug: Oral calcitonin at dinnertime;   Drug: Oral placebo at dinnertime;   Drug: Oral calcitonin at bedtime;   Drug: Oral placebo at bedtime
3 Completed
Has Results
A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women
Condition: Osteoporosis
Interventions: Drug: Recombinant Salmon Calcitonin (rsCT);   Drug: Oral Tablet;   Drug: Nasal Spray
4 Completed
Has Results
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women
Condition: Phase 1 Pharmacodynamic Study
Interventions: Drug: Oral rsCT tablet;   Drug: Oral Placebo Tablet;   Drug: Fortical (rsCT) nasal spray
5 Active, not recruiting Post Authorisation Safety Study (PASS) on Patients With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention:
6 Completed Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants
Conditions: Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal B vaccine;   Biological: Control;   Biological: Meningococcal B vaccine with antipyretic

Indicates status has not been verified in more than two years